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Abstract
Tributyltin (TBT) activates the mitogen activated protein kinase (MAPK), p44/42 in human natural
killer (NK) cells. TBT also reduces NK cytotoxic function and decreases the expression of several
NK-cell proteins. To understand the role that p44/42 activation plays in TBT-induced loss of NK
cell function, we have investigated how selective activation of p44/42 by phorbol 12-myristate 13-
acetate (PMA) affects NK cells. Previously we showed that PMA caused losses of lytic function
similar to those seen with TBT exposures. Here we examined activation of p44/42 in the regulation
of NK-cell protein expression and how this regulation may explain the protein expression changes
seen with TBT exposures. NK cells exposed to PMA were examined for levels of cell-surface
proteins, granzyme mRNA, and perforin mRNA expression. The expression of CD11a, CD16, CD18,
and CD56 were reduced, perforin mRNA levels were unchanged and granzyme mRNA levels were
increased. To verify that activation of p44/42 was responsible for the alterations seen in CD11a,
CD16, CD18, and CD56 with PMA, NK cells were treated with the p44/42 pathway inhibitor
(PD98059) prior to PMA exposures. In the presence of PD98059, PMA caused no decreases in the
expression of the cell-surface proteins. Results of these studies indicate that the activation of p44/42
may lead to the loss of NK cell cytotoxic function by decreasing the expression of CD11a, CD16,
CD18, and CD56. Further, activation of p44/42 appears to be at least in part responsible for the TBT-
induced decreases in expression of CD16, CD18, and CD56.
INTRODUCTION
Natural Killer (NK) cells are a subset of lymphocytes that are capable of killing (lysing) tumor
cells, virally infected cells and antibody-coated cells. NK cells do not require prior sensitization
in order to kill their targets (Lotzova, 1993; Vivier et al., 2004). They are the earliest and
possibly predominant immune defense against tumor cells (Lotzova, 1993; O’Shea and
Ortaldo, 1992; Trinchieri, 1989). They are responsible for limiting the spread of blood borne
metastases, as well as limiting the development of primary tumors (Kiessling and Haller,
1978; Hanna, 1980). NK cells are also crucial in preventing viral infections as evidenced by
greatly increased incidence of viral infection seen in individuals where the NK subset of
lymphocytes is completely absent (Fleisher et al., 1982; Biron et al., 1989).
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When an NK cell binds to a susceptible target cell, protein tyrosine kinases (PTKs) are activated
(Gismondi et al., 2000) leading to subsequent activation of the mitogen activated protein kinase
(MAPK) signaling cascade in NK cells (Vivier et al., 2004; Djeu et al., 2002). The MAPKs
present in NK cells include p44/42 (also known as ERK1/2), p38, and JNK. Activation of
p44/42 appears to be a part of the mechanism which controls the release of cytotoxic granules
(which contain the lytic proteins granzyme B and perforin) from the NK cells onto target cells
(Orange, 2008; Trotta et al., 1998; Trotta et al., 2000; Wei et al., 1998) and is thus needed in
the lytic response of NK cells.
Tributyltin (TBT) is an environmental contaminant due to having been used in wood
preservation, marine antifouling paints, disinfection of circulating industrial cooling waters,
and slime control in paper mills (Kimbrough, 1976; Roper, 1992; Yamada et al., 1993). TBT
has been detected in a number of household products (Yamada et al., 1993) and in human food,
such as fish (Kannan et al., 1995a,b,c) and in human blood (Kannan et al., 1999; Whalen et
al., 1999). The levels of TBT found in human blood samples ranged from a high of 260 nM to
undetectable. Of the 38 blood samples (each from a different donor) that were studied 12 of
the 38 (32%) showed levels of TBT between 25 to 265 nM and 19 of the 38 (50%) had levels
between 3-25 nM (Kannan et al., 1999; Whalen et al., 1999).
TBT-induced loss of NK function could leave exposed individuals with an increased risk of
viral infection and /or tumor formation. In vivo studies have shown decreased NK cell function
in TBT exposed adult mice (Ghoneum et al., 1990). Alternatively, a study conducted on rats
that were exposed to TBT both in-utero and post-natally showed increased splenic NK activity
(Tryphonas et al., 2004). A study of weanling male rats administered bis(tri-n-butyltin) oxide
(TBTO) for 106 weeks showed increased tumors (Wester et al., 1990). The reasons for these
differences may be due to species (mouse versus rat), the method of administration of the TBT,
or form of TBT. However, due to the demonstrated loss of NK function seen in at least one
species in response to TBT, it was important to determine its effects on human immune system
function. Previously, we have shown that in vitro exposures of human NK cells to TBT (at
concentrations in the range found in blood, 300-25 nM) caused a loss of their ability to both
lyse and bind to susceptible target cells (Whalen et al., 1999; Dudimah et al., 2007; Whalen
et al., 2002). Our past studies have also shown that TBT-exposed human NK cells demonstrated
a measureable decrease in the cell-surface proteins CD16, CD18, and CD56 that are involved
in NK binding to targets (Whalen et al., 2002). There were also TBT-induced decreases in the
cytolytic granule proteins, granzyme B and perforin (Thomas et al., 2004). As mentioned
above, the cytolytic granule proteins are required to lyse targets. The importance of the role of
MAPK activation in the regulation of the NK lytic response is described above. We have shown
that TBT causes a significant (as much as 9 fold) increase in the activation of the MAPK,
p44/42 (Aluoch and Whalen 2005; Aluoch et al., 2006) as well as other effects such as
activation of the other MAPKs. This spurious activation of MAPKs by TBT leaves the NK
cell unable to activate the MAPK signaling pathways when it subsequently comes in contact
with a susceptible target cell and thus diminishes the NK cells ability to kill the target cell
(Aluoch and Whalen 2005; Aluoch et al., 2006).
The role that activation of p44/42 (versus activation of the other MAPKs) plays in the loss of
NK cell lytic function has been previously examined (Dudimah et al., 2010) by selectively
stimulating (Chang et al., 2005) the p44/42 MAPK pathway using phorbol 12-myristate 13-
acetate (PMA). Stimulation of p44/42 (to an extent similar to what was seen with TBT) (Aluoch
and Whalen 2005; Aluoch et al., 2006) was able to decrease NK lytic function in a manner
similar to that seen with TBT (Dudimah et al., 2010).
In this study, our goal is to elucidate the role that activation of the MAPK, p44/42, plays in
regulating the expression of cell-surface proteins in NK cells and to investigate whether p44/42
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activation (alone) can cause the TBT-induced changes in NK protein expression. The overlap
between changes in protein expression seen with TBT and those seen with selective activation
of p44/42 by PMA (Chang et al., 2005) will indicate what role (if any) p44/42 activation plays
in TBT-induced alterations of protein expression. The cell-surface proteins examined are those
that have been shown to have a role in NK cell interactions with targets, CD11a, CD16, CD18,
and CD56 (Lotzova, 1993) as well as CD2 (which served as a negative control). CD16 and
CD56 appear to be important in activation of the lytic response (Lotzova, 1993) and they (plus
CD18) are decreased with TBT exposures (Whalen et al., 2002).
MATERIALS AND METHODS
Isolation of NK cells
Peripheral blood from healthy adults (male and female) volunteer donors was used for this
study. Buffy coats (source leukocytes) obtained from either the American Red Cross (Portland,
OR) or Key Biologics, LLC (Memphis, TN) were used to prepare NK cells. Highly purified
NK cells were obtained using a rosetting procedure. Buffy coats were mixed with 0.6-0.8 mL
of RosetteSep human NK cell enrichment antibody cocktail (StemCell Technologies,
Vancouver, British Columbia, Canada) per 45 mL of buffy coat. The mixture was incubated
for 20 min at room temperature (~ 25° C). Following the incubation, 5-8 mL of the mixture
was layered onto 4 mL of Ficoll-Hypaque (1.077 g/mL) (MP Biomedicals, Irvine, CA) and
centrifuged at 1200 g for 30-40 min. The cell layer was collected and washed twice with
phosphate buffered saline (PBS) pH 7.2 and stored in complete media (RPMI-1640
supplemented with 10% heat-inactivated bovine calf serum (BCS), 2 mM L-glutamine and 50
U penicillin G with 50 μg streptomycin/mL (Mediatech, Inc. Herndon, VA)) at 1 million cells/
mL at 37°C, 5%CO2. The resulting cell preparation was >95% CD16+, 0% CD3+ by
fluorescence microscopy (Whalen et al., 2002) or flow cytometry in the current study.
Chemical preparation
PMA (Fisher Scientific, Suwanee, GA) and PD98059 (EMD Chemicals, Inc. Gibbstown, NJ)
were dissolved in dimethylsulfoxide (DMSO, Sigma-Aldrich, St. Louis, MO) to give 10 mM
stock solutions. TBT (Sigma-Aldrich, St. Louis, MO) was prepared as a 1 mM stock solution
in de-ionized-distilled water. Desired concentrations of the compound were prepared by
dilution of the stock into media.
Cell Treatments
NK cells (at a concentration of 1.5 million cells/mL) were exposed in the following ways. 1.
PMA for 24 h: Cells were treated with the appropriate control or 2.5 nM PMA for 24 h at 37°
C, 5%CO2. For mRNA analysis and western blot analysis, cells were treated with control, 10,
and 2.5 nM or control, 10, 5, 2.5 and 1 nM PMA, respectively. 2. PMA for 1 h followed by 24
h in PMA-free media: Cells were treated with control (appropriate DMSO control), 5 nM PMA,
2.5 nM PMA, 1 nM PMA, and 0.5 nM PMA for 1 h. Following the incubation the cells were
washed twice with media to remove the incubation media and then placed in compound-free
media for 24 h at 37°C, 5%CO2. 3. Pre-treatments with PD98059 prior to exposure to varying
concentrations of PMA: Cells were pre-incubated with 50 μM PD98059 or appropriate DMSO
control for 1 h prior to the addition of control (for PMA), 5 nM PMA, 2.5 nM PMA, 1 nM
PMA, or 0.5 nM PMA. The cells were then incubated with these PMA concentrations for 1 h.
Thus, there was 1 tube of cells that had only control treatments and 5 tubes that had control for
the 1 h pre-incubation which was then followed by a 1 h incubation with each of the 5 different
PMA concentrations. There were also 5 tubes that had 50 μM PD98059 for the 1 h pre-
incubation which was then followed by a 1 h incubation with each of the 5 PMA concentration.
After the total 2 h of incubation the cells were washed twice with media to remove the
incubation media and then placed in compound-free media for 24 h at 37°C, 5%CO2. 4.
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Treatment with TBT for 1 h followed by 24 h in TBT-free media: Cells were treated with
control, 300 nM TBT, and 200 nM TBT for 1 h. Following the incubation the cells were washed
twice with media to remove the incubation media and then placed in TBT-free media for 24 h
at 37°C, 5%CO2. 5. Pre-treatments with PD98059 prior to exposure to varying concentrations
of TBT: Cells were pre-incubated with 50 μM PD98059 or appropriate DMSO control for 1 h
prior to the addition of control, 300 nM TBT, or 200 nM TBT. The cells were then incubated
with these TBT concentrations for 1 h. After the total 2 hours of incubation the cells were
washed twice with media to remove the incubation media and then placed in compound-free
media for 24 h at 37°C, 5%CO2.
Cell Viability
Cell viability was determined by trypan blue exclusion (Whalen et al., 2003). Cell number and
viability, assessed at the beginning and end of each exposure period, did not vary significantly
among experimental conditions and control conditions for any of the cell treatments listed
above.
Flow Cytometry
After the appropriate incubation with the compound, the cells were washed twice with ice-cold
PBS and 100 μL of cell suspension (250,000-500,000 cells) was labeled with 10 μL (Whalen
et al., 2002) of one of the following antibodies: anti-CD2, anti-CD11a, anti-CD16, anti-CD18,
or anti-CD56 (Pharmingen, San Diego, CA). The antibodies were FITC-conjugated or PE-
conjugated monoclonal antibodies. Appropriate FITC-conjugated and PE-conjugated isotype
control antibodies (Phamingen, San Diego, CA) were used. The antibody-containing cell
suspensions (final concentration 10 μL monoclonal antibody per 100 μL) were then incubated
for 30 minutes on ice, in the dark. Following the incubation period the cells were washed twice
with ice-cold PBS (0.5-1 mL) and suspended in 250 μL of ice-cold 1% paraformaldehyde in
PBS. Samples were analyzed using a FACScan flow cytometer from Becton Dickinson
Immunocytometry Systems, Inc. (BDIS). Instrument performance was standardized daily
using Calibrite beads (BDIS) and the same instrument settings were used for all acquisitions
of stained cells. The cell preparations were sufficiently uniform (with respect to cell size and
viability) to use the same FSC, SSC, and FL settings (Whalen et al., 2002). The acquisition
and analysis software for flow cytometry data was CELLQuest v3.3 from BDIS running on a
G4 Apple computer.
Western Blot
Cell lysates from NK cells treated with control, 10 nM, 5 nM, 2.5 nM, 1 nM and 0.5 nM PMA
for 24 h prior to lysis were run on 10% SDS-PAGE (sodium dodecylsulfate polyacrylamide
gel electrophoresis) and transferred to PVDF (polyvinylidene Difluoride) membrane. The
PVDF was immunoblotted with specific primary antibodies to either CD16, granzyme B,
perforin, or β-actin. Antibodies were visualized using the ECL chemiluminescent detection
system (Amersham, Piscataway, NJ) and a Kodak Image Station (Kodak, Rochester, NY). The
density of each protein band was determined by densitometric analysis using the Kodak Image
Station analysis software. A given experimental set-up always had its own internal control.
Thus, differences in protein expression were determined relative to the internal control. β-actin
levels were determined for each condition to verify that equal amounts of protein were loaded.
In addition, the density of each protein band was normalized to β-actin to correct for small
differences in protein loading among the lanes (Aluoch and Whalen, 2005).
RNA isolation and real-time quantitative RT-PCR
Human NK cells were isolated from whole blood as described in the section under NK cell
isolation, treated with the compounds of interest for the desired lengths of time before
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proceeding with total RNA extraction. Total RNA was extracted using an RNeasy mini kit
(Qiagen; Valencia, CA) and its concentration determined by reading the optical density at 260
nm. Possible genomic DNA contamination was removed by on-column DNase digestion using
the RNase–free DNase set. Two million NK cells per treatment condition were used. Samples
were diluted in RNase-free water to 15 ng/uL and stored in micro-centrifuge tubes at −80 °C.
Real-time quantitative RT-PCR (qRT-PCR) was performed with an iCycler iQ System. Primers
were designed using Primer Express 2.0 software (ABI). Primers were designed in such a way
that they included at least one intron-exon junction so as to increase the specificity for the target
genes and to minimize the amplification of closely related genes. Genes of interest were
compared to closely related genes using BLAST and primers were designed based on divergent
regions of the target gene sequence compared to those of the highly related genes (primer
sequences are shown in Table 1). The QuantiTect SYBR green RT-PCR kit (Qiagen) and gene-
specific PCR primers were used in a 20 μL reaction following protocols recommended by the
manufacturer. To ensure that there is no significant difference in the concentration of total
RNA in each sample, 18s RNA was analysed by qRT-PCR.
Generally, the PCR mixture (20 μL) contained 30 ng of total RNA and 0.2 μM each primer,
10 nM fluorescein calibration dye, 0.2 μL RT mix and 10 μL of 2× master mix. . Reverse
transcription was performed for 20 min at 50 °C, followed by amplification for 35 cycles (15
s at 94 °C, 60 s at 60 °C) after an initial activation at 95 °C for 15 min. Melting curve analysis
was carried out to determine the specificity of amplification. Analysis of results was done using
the comparative Ct method. This involves comparing the Ct values of the samples of interest
with a control or calibrator such as a non-treated sample. The comparative Ct method is also
known as the delta Ct method, where [delta]Ct = [delta]Ct,sample - [delta]Ct,reference where
[delta]Ct,sample is the Ct value for any treated sample and [delta]Ct, reference is the Ct value for
the calibrator or untreated sample. The mRNA levels were represented in arbitrary units.
Statistical Analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student’s t test. Data were
initially compared within a given experimental setup by ANOVA. A significant ANOVA was
followed by pair wise analysis of control versus exposed data using Student’s t test.
RESULTS
Effect of 24 h exposures to 2.5 nM PMA on NK cell-surface protein expression
NK cells were treated with 2.5 nM PMA for 24 h and then analyzed using flow cytometry. The
expression of CD2, CD11a, CD16, CD18, and CD56 were measured. CD2 levels were not
expected to change and served as a negative control. The results are summarized in Table 2.
Exposure of NK cells to this concentration of PMA resulted in a significant loss of the cell-
surface proteins CD11a, CD16, CD18, and CD56 (P<0.05) compared to the control. 2.5 nM
PMA has previously been shown to activate p44/42 in NK cells by approximately 10 fold
(Dudimah et al., 2010). The treatment resulted in expression of CD11a at a level of 30% of
that seen in control cells (a 70% loss of CD11a), CD16 expression was 17% of control (83%
decrease), CD18 was expressed at 37% of control levels (63% decrease), and CD56 expression
was 50% of control. This treatment did not result in a decrease in CD2 expression. Figure 1
shows histograms from a representative flow cytometry experiment for each of the cell-surface
proteins whose expression was decreased. All studies were carried out at least three times using
cells that were prepared from three different donors (n≥3).
Dudimah et al. Page 5













Effects of 1 h exposures to 5 nM PMA followed by 24 h in PMA-free media on NK cell-surface
protein expression
NK cells were exposed to a PMA concentration of 5 nM for 1 h after which the cells were
washed twice with media then re-suspended in media for 24 h before flow cytometry analysis.
This concentration of PMA resulted in a significant loss of CD11a, CD16, and CD18 expression
compared to the control (P<0.05). 5 nM PMA has been shown to activate p44/42 by
approximately 12 fold within 10 min (Dudimah et al., 2010). CD11a was expressed at 32% of
control levels, while CD16 and CD18 were expressed at 11% and 31% of the levels seen in
control cells. Thus, there were reductions of CD11a, CD16, and CD18 in treated cells compared
to control cells of 68, 89, and 69% respectively (Table 2). There was again no significant change
in CD2 expression. Figure 2 shows histograms from a representative flow cytometry
experiment for those proteins whose expression was decreased.
Effects of 1 h exposures to 2.5 nM PMA followed by 24 h in PMA-free media on NK cell-surface
protein expression
CD11a, CD16, CD18, and CD56 all showed significant reductions in expression compared to
control cells (P<0.05) (Table 2). 2.5 nM PMA as mentioned above, caused about 10 fold
activation of p44/42 (Dudimah et al., 2010). The only cell-surface protein that was not
significantly reduced by this treatment was CD2. Figure 3 shows histograms from a
representative flow cytometry experiment.
Effects of 1 h exposures to 300 nM and 200 nM TBT followed by 24 h in TBT-free media on
NK cell-surface protein expression
When NK cells were treated with 300 nM TBT for 1 h followed by 24 h in TBT-free media
the expression of CD16 was 70% of that seen in control cells. Expression of CD18 was 89%
of that seen in control cells and CD56 was present on the NK cell surface at 62% of levels seen
in control cells. Thus, there were significant decreases in CD16 (30%), CD18 (11%), and CD56
(38%) expression 24 h following a 1 h exposure to 300 nM TBT (Table 2). Exposure of NK
cells to 300 nM TBT causes an average increase in p44/42 activation of about 9 fold (Aluoch
et al., 2006). Exposure to 200 nM TBT for 1 h followed by 24 h in TBT- free media led to
decreased expression of both CD16 and CD56 (Table 2). CD16 expression was 82% of that
seen in control cells while CD56 expression was 76% of that seen in control NK cells. Thus,
expression of CD16 was decreased by 18% and that of CD56 was decreased by 24%. The
increase in p44/42 activation seen with 200 nM TBT averaged 6 fold above control (Aluoch
et al., 2006), which is between that seen with 2.5 and 1 nM PMA. Figure 4 shows data from
representative flow cytometry experiments for CD16, CD18, and CD56 for the exposure to
300 nM TBT and CD16 and CD56 for both of the TBT treatments.
Effects of 1 h exposures to 1 nM PMA followed by 24 h in PMA-free media on NK cell-surface
protein expression
Results from the 1 nM treatment (the average increases in p44/42 activation with 1 nM PMA
was 2.3 fold (Dudimah et al., 2010)) did not show a significant loss in CD56 and CD2.
However, there were a significant decreases in the expression of C11a, CD16, and CD18
(P<0.05) (Table 2). CD11a expression was 62% of that seen in control cells, while CD16 and
CD18 expression were 47% and 67%, respectively, of that seen in control cells. Put in terms
of decreases, CD11a decreased by 38%, CD16 by 53%, and CD18 by 33%. Figure 5 shows
histograms from a representative flow cytometry experiment.
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Effects of 1 h exposures to 0.5 nM PMA followed by 24 h in PMA-free media on NK cell-surface
protein expression
When NK cells were treated with 0.5 nM PMA (which causes no significant increases in p44/42
activation (Dudimah et al., 2010)) there was no significant change in any of the cell-surface
proteins studied compared to the control.
Effect of 1 nM PMA or 300 nM TBT on NK cells pretreated with p44/42 pathway inhibitor
(PD98059) on cell-surface protein expression
NK cells were treated with 50 μM PD98059 (a selective inhibitor of the MAPK kinase
(MEK1/2) for p44/42) for 1 h prior to treating with 1 nM PMA for 1 h. The cells were then
washed twice with media before they were re-suspended in PMA free media for 24 h before
flow cytometry analysis. The results showed that PMA did not cause a significant reduction
in cell-surface proteins of NK cells pretreated with PD98059 (Table 2). When NK cells were
treated with the MEK1/2 inhibitor 1 h prior to exposure to 300 nM TBT, there were no
significant decreases in either CD16 or CD18. The decreases in CD56 while still occurring
were reduced (Table 2). Figure 6 shows histograms from a representative flow cytometry
experiment.
Effects of 24 h exposures to PMA on the levels of total CD16 protein expression in NK cells
NK cells were exposed to PMA concentrations between 10 and 1 nM for 24 h before western
blot analysis. The results from this treatment did not show any significant changes in CD16
protein expression compared to the control. Thus, although there were very significant
decreases in the expression of CD16 at the cell surface with PMA exposures of 24 h (Table 2),
there were no significant decreases in the total amount of CD16 present in the NK cells. Figure
7A shows the combined results from three separate experiments and Figure 7B show results
from a representative experiment.
Effects of 24 h exposures to PMA on the levels of granzyme B and perforin mRNA and protein
levels in NK cells
There was a significant increase in granzyme mRNA expression for both the 10 and 2.5 nM
treated samples compared to the control samples. Both the 10 and 2.5 nM concentrations
resulted in about 3 fold increase in mRNA compared to the control. There was no significant
change in perforin mRNA expression compared to the control. Results are shown in Figure
8A. Figure 8B shows that neither granzyme B nor perforin protein levels were altered by
exposures to a range of PMA concentrations for 24 h, data are from a representative experiment.
DISCUSSION
Studies with TBT in human NK cells have shown an association of the activation of MAPKs
p44/42, p38, and JNK and loss of NK cell lytic function (Aluoch and Whalen, 2005; Aluoch
et al., 2006; Aluoch et al., 2007). A separate study showed that selective activation of the
p44/42 signaling pathway in NK cells could result in losses of lytic function similar to those
seen with TBT, indicating that the TBT-induced activation of p44/42 may be at least in part
responsible for the loss of lytic function (Dudimah et al., 2010). In this study, our goal is to
elucidate the role that activation of p44/42 plays in regulating the expression of cell-surface
proteins in NK cells and to investigate whether p44/42 activation (alone) can cause the TBT-
induced changes in NK protein expression (Whalen et al., 2002; Thomas et al., 2004). The
concentrations of PMA used were those that gave a similar level of p44/42 activation (Dudimah
et al., 2010) as seen with TBT exposures (Aluoch et al., 2006). The proteins studied were those
whose levels change when NK cells are exposed to TBT, which include the cell surface proteins
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CD16, CD18, CD56, and the cytolytic proteins granzyme B and perforin (Whalen et al.,
2002; Thomas et al., 2004).
The results showed significant reductions in the expression of CD11a, CD16, CD18 and CD56
with 24 h exposures to PMA as well as 1 h exposures to PMA followed by a 24 h period in
PMA-free media (Table 2). When NK cells were pretreated with the p44/42 pathway inhibitor
PD98059 prior to a 1 nM exposure to PMA, there was no significant change in the expression
of any of the cell-surface proteins, thus establishing that p44/42 activation was responsible for
the decreased cell-surface protein expression seen with this PMA exposure. The higher
concentrations of PMA were also tested for reversal of their effects on cell-surface proteins by
PD98059. The effects of these concentrations of PMA could not be fully reversed. These results
indicated that there may be other effects of PMA on NK cells that occur at higher concentrations
of PMA, which are not due to its effects on p44/42. PMA is known to be a potent activator of
protein kinase Cs (PKCs) (Liu and Heckman, 1998) and the activation of PKC in NK cells
may have effects on cell surface protein expression.
Exposure of NK cells to 300 nM TBT for 1 h followed by 24 h in TBT-free media caused
alterations of CD16 and CD18 expression that were in the same direction as were seen with 1
h exposures to 1 nM PMA and/or 2.5 nM PMA followed by 24 h in PMA-free media although
the magnitude of the changes was different. 1 nM PMA decreased both CD16 and CD18 to a
greater extent than did 300 nM TBT (Table 2). The decrease in CD56 seen with 300 nM TBT
was not seen with 1 nM PMA however, a decrease in CD56 of slightly greater magnitude was
seen at 2.5 nM PMA (Table 2).
The fact that the decreases in CD18 and CD16 seen with exposure to 300 nM TBT for 1 h
followed by 24 h in TBT-free media were due to activation of p44/42 was verified by the fact
that the p44/42 pathway inhibitor PD98059 prevented these decreases. The TBT-induced
decreases in CD56 were lessened when p44/42 activation was blocked, but not completely
remediated. Again, these results indicate that the decreases in CD16 and CD18 seen with TBT
appear to be due to the activation of p44/42. The decreases in CD56 appear to be in part due
to p44/42 activation, however it appears that another consequence of TBT exposures such as
p38 or JNK activation may also be responsible for TBT-induced decreases in CD56 (Aluoch
and Whalen, 2005; Aluoch et al., 2006).
We went on to examine if total CD16 levels or only cell-surface expression of CD16 was being
affected by p44/42 activation. Western blot analysis of NK cells exposed to PMA showed no
decreases in CD16. Since CD16 protein levels did not change, the loss of CD16 cell-surface
protein with the same PMA exposures suggests that the loss at the cell surface may be due to
a disruption of trafficking of the proteins to the cell-surface. These data suggest that p44/42 in
involved in the regulation of the movement of at least CD16 to and/or from the plasma
membrane. Other studies have indicated that activation of phosphatidylcholine (PC)-specific
phospholipase C may play a role in the internalization of CD16 from the plasma membrane to
the cytoplasmic compartment (Cecchetti et al., 2007). The current study indicates that p44/42
may be playing a role in the trafficking of CD16 NK-cell-surface proteins between the
cytoplasmic compartment and the plasma membrane. CD16 has a role as an activating receptor
of the NK lytic process with antibody coated (Lotzova, 1993) and tumor targets (Mandelboim
et al., 1999), while CD18 and CD56 appear to be important in the binding of NK cells to targets
(Lotzova, 1993). As a result of reduced expression of CD16 caused by p44/42 activation, the
ability of NK cells to kill target cells could be compromised (Mandelboim et al., 1999).
In past studies we have found that TBT induced decreases not only in cell surface proteins such
as CD16, CD18, and CD56 (Whalen et al., 2002), but also the cytolytic proteins, granzyme B
and perforin (Thomas et al., 2004). The decreases in expression of granzyme B and perforin
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in response to a 1 h exposure to 300 nM TBT followed by 24 h in TBT-free media were seen
both at the level of total protein and mRNA (Thomas et al., 2004). In an effort to determine
the role (if any) that TBT–induced activation of p44/42 played in TBT-induced decreases in
granzyme B and perforin, we looked at the effects of selectively activating p44/42 using PMA
on both protein expression and mRNA expression. Unlike exposure to TBT (Thomas et al.,
2004), PMA caused no measureable change in the protein expression of granzyme B or perforin
(Figure 8B). Additionally PMA caused no significant changes in the expression of the mRNA
for perforin (Figure 8A). However, the expression of mRNA for granzyme B was 3 times
greater in PMA exposed cell as in the control (Figure 8A). These results indicated that while
the transcription of granzyme was increased by p44/42 activation this does not result in
increased levels of expression of the protein. One explanation for this may be that the stability
of the mRNA is decreased when p44/42 is activated leading to no net increase in granzyme
levels in the cell. It may also be that p44/42-stimulated release of cytolytic granules (Trotta et
al., 1998) is just being compensated for by the increase in synthesis and thus no net increase
is seen. These results also suggest that other molecular consequence of TBT exposures (beyond
p44/42 activation) are involved in the TBT-induced changes in the levels of the cytolytic
proteins. We have shown in past studies that TBT also activates the MAPK, p38 (Aluoch et
al., 2006) and causes an influx of extracellular calcium into the NK cell (Lane et al., 2010),
which may explain the divergence of TBT and PMA effects on these proteins.
In summary the results of the current study show: 1) cell-surface expression of CD11a, CD16,
CD18, and CD56 in human NK cells is regulated by the MAPK, p44/42. 2) TBT-induced
decreases in CD16, and CD18 appear to be attributable to the TBT-induced activation of p44/42
and TBT-induced decreases in CD56 appear to be only partially due to p44/42 activation. 3)
changes in cell-surface protein expression of CD16 caused by PMA activation of p44/42 are
not due to decreases in the total amount of CD16 in the NK cells, suggesting that p44/42 may
be involved in regulating the trafficking of CD16 from the cytoplasmic compartment to the
plasma membrane. 4) there is no alteration of expression the cytolytic proteins, granzyme B
and perforin in response to activation of p44/42, mRNA for granzyme B was increased by
p44/42 activation, indicating that TBT-induced decreases in cytolytic proteins are not due to
TBT-induced activation of p44/42.
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Effect of a 24 h exposure to 2.5 nM PMA on NK cell-surface protein expression. A) CD11a.
Dashed line = IgG isotype control, thin solid line = control NK cells, bold line = PMA treated
cells, y-axis is cell number, and the x-axis is fluorescence intensity. B) CD16. C) CD18. D)
CD56. Representative histograms are shown. Results were replicated in NK cells prepared
from three separate donors, n=3.
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Effects of a 1 h exposure to 5 nM PMA followed by 24 h in PMA-free media on NK cell-
surface protein expression A) CD11a. Dashed line = IgG isotype control, thin solid line =
control NK cells, bold line = PMA treated cells, y-axis is cell number, and the x-axis is
fluorescence intensity. B) CD16. C) CD18. Results were replicated in NK cells prepared from
three separate donors, n=3.
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Effects of a 1 h exposure to 2.5 nM PMA followed by 24 h in PMA-free media on NK cell-
surface protein expression A) CD11a. Dashed line = IgG isotype control, thin solid line =
control NK cells, bold line = PMA treated cells, y-axis is cell number, and the x-axis is
fluorescence intensity. B) CD16. C) CD18 . D) CD56. Results were replicated in NK cells
prepared from 5 separate donors, n=5.
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Effects of 1 h exposures to 300 nM and 200 nM TBT followed by 24 h in TBT- free media on
NK cell-surface protein expression A) effect of 300 nM TBT on CD16. Dashed line = IgG
isotype control, thin solid line = control NK cells, bold line = TBT treated cells, y-axis is cell
number, and the x-axis is fluorescence intensity. B) effect of 300 nM TBT on CD18. C) effect
of 300 nM TBT on CD56. D) effect of 200 nM TBT on CD16. E) effect of 200 nM TBT on
CD56. Results were replicated NK cells prepared from 5 separate donors, n=5.
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Effects of 1 h exposures to 1 nM PMA followed by 24 h in PMA-free media on NK cell-surface
protein expression A) CD11a. Dashed line = IgG isotype control, thin solid line = control NK
cells, bold line = PMA treated cells, y-axis is cell number, and the x-axis is fluorescence
intensity. B) CD16. C) CD18. Results were replicated NK cells prepared from 5 separate
donors, n=5.
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Effects of 1 nM PMA or 300 nM TBT on NK cells pretreated with p44/42 inhibitor (PD98059)
on cell-surface protein expression. A) effect of 1 nM PMA on CD11a. Dashed line = IgG
isotype control, thin solid line = 1 nM PMA treated cells, bold line = NK cells pretreated with
PD98059 before 1 nM PMA treatment, y-axis is cell number, and the x-axis is fluorescence
intensity. B) effect 1 nM PMA on CD16. C) effect of 1 nM PMA on CD18. D) effect of 300
nM TBT on CD16. Dashed line = IgG isotype control, thin solid line = 300 nM TBT treated
cells, bold line = NK cells pretreated with PD98059 before 300 nM TBT treatment, y-axis is
cell number, and the x-axis is fluorescence intensity. E) effect of 300 nM TBT on CD18. F)
effect of 300 nM TBT on CD56. Results were replicated in NK cells prepared from 3 separate
donors, n=3.
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Effects of 24 h exposures to 10-1 nM PMA on levels CD16 in pure NK cells: A) The band
densities for the PMA-treated cells were normalized to control and are given as fold increase
over the control There was no statistically significant change in CD16 expression as compared
to control. Values are mean ± S.D. from at least three separate experiments. B) Representative
western blot of total CD16 expression after 24 h exposure of NK cells to PMA. Results were
replicated in NK cells prepared from 3 separate donors, n=3.
Dudimah et al. Page 20














Effects of exposures of human NK cells to PMA on the expression of granzyme B, perforin
and beta actin. A) RNA levels in NK cells were treated with 2.5 and 10 nM of PMA for 24 h
before the RT-PCR experiment. Values are mean±S.D. of four different samples from different
donors, triplicate determinations, n=12. A significant difference in the expression of RNA in
treated cells compared to their respective controls is indicated by an asterisk. The viability of
PMA treated cells was identical to that of control cells. B) Protein levels in NK cells treated
with 0-10 nM PMA for 24 h. Experiments carried out in 3 separate donors, n=3.
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Table 1
Quantitative RT -PCR (TaqMan) Primers
Gene Primer Sequence Amplicon
Size (bp)
18S RNA Forward 542F TCGAGGCCCTGTAATTGGAA
Reverse 602R CCCTCCAATGGATCCTCGTT 71
Granzyme Forward 68F TGCAACCAATCCTGCTTCTG
Reverse 134R CCGATGATCTCCCCTGCAT 67
Perforin Forward 1638F CTCCTTGGCACCTGTGATCAG
Reverse 1706R GCCATGATTCAGGTTGCATCT 69
Beta-Actin Forward 421F AAGGCCAACCGCGAGAA
Reverse 500R ACAGCCTGGATAGCAACGTACA 80
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